Miriam E. Tucker November 19, 2024 0155 Added to Email Alert WASHINGTON, DC — Use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduced the need for urate-lowering therapy (ULT) and gout flare therapies in people who had both type 2 diabetes (T2D) and gout, new research has found. Data from a large US claims database showed that...
Tag: <span>Gout medicine</span>
Post
Gout medicine improves survival for heart failure patients, study finds
UNIVERSITY OF VIRGINIA HEALTH SYSTEM IMAGE: SULA MAZIMBA, MD, MPH, IS A HEART FAILURE EXPERT AT UVA HEALTH AND THE UVA SCHOOL OF MEDICINE. CREDIT: UVA HEALTH A common gout medication, colchicine, significantly improved survival rates for patients hospitalized with worsening heart failure, a UVA Health study found. The researchers believe colchicine could also reduce...